Related Experiment Video
Updated: Aug 10, 2026
08:44
A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
Published on: April 19, 2020
Abnormal DNA content in liver-cell dysplasia: a flow cytometric study
M Roncalli1, M Borzio, B Brando
12nd Department of Pathology, University of Milan, Italy.
International Journal of Cancer
|August 15, 1989
Summary
Liver-cell dysplasia (LCD) exhibits heterogeneous ploidy. Abnormal DNA content in some LCD cases suggests a pre-neoplastic nature, indicating potential progression to liver cancer.
Area of Science:
- Hepatology
- Molecular Pathology
- Cytometry
Background:
- Liver-cell dysplasia (LCD) is a poorly understood condition.
- Its relationship to neoplastic liver disease requires clarification.
Purpose of the Study:
- To investigate the DNA content and ploidy of hepatocytes in liver-cell dysplasia.
- To compare these findings with non-neoplastic liver conditions and hepatocellular carcinoma.
Main Methods:
- Flow cytometry was used to analyze DNA content in hepatocytes from archival paraffin-embedded liver tissue.
- DNA index (DI) was calculated using normal hepatocytes as internal references.
- Analysis focused on diploid and non-diploid DNA stemlines.
Main Results:
- Eight of 22 (36%) liver-cell dysplasia cases showed abnormal DNA content, unlike non-neoplastic controls (0/11).
- Hepatocellular carcinomas frequently displayed abnormal, multi-modal DNA content (8/10 cases).
- Liver-cell dysplasia demonstrated heterogeneous ploidy, with some cases exhibiting aneuploidy.
Conclusions:
- Liver-cell dysplasia is a heterogeneous lesion regarding DNA content.
- The presence of abnormal DNA content in some LCD cases supports its role as a pre-neoplastic lesion.
- Further research is warranted to understand the progression from LCD to hepatocellular carcinoma.
